Publications

5808 Results

Genomic subtypes of nucleophosmin (NPM1) mutations are associated with clinical outcome in AML – A COG and SWOG intergroup collaboration

Authors
D Selim;T Alonzo;M Othus;R Gerbing;F Ostronoff;K Tarlock;E Kutny;R Aplenc;A Kolb;J Radich;F Appelbaum;A Gamis;D Stirewalt;S Meshinchi
Journal / Conference
Blood 128:285; American Society of Hematology Annual Meeting (December 3-6, 2016,San Diego, CA), oral
Year
2016
Research Committee(s)
Leukemia
Study Number(s)
S0106

Novel associations between mutations, biological and clinical parameters in untreated CLL: Data from the ECOG-E1912, a Randomized Phase III Study of the ECOG-ACRIN Cancer Research Group

Authors
E Braggio;S Garcia;V Wang;L Bruins;C Lesnick;R Fonseca;N Kay;S O'Brien;T Shanafelt
Journal / Conference
Blood 128:4373; American Society of Hematology Annual Meeting (December 3-6, 2016, San Diego, CA), poster
Year
2016
Research Committee(s)
Leukemia
Study Number(s)
CTSU/E1912

Neutrophil-to-lymphocyte ratio as a bladder cancer biomarker: Assessing prognostic and predictive value in SWOG 8710

Authors
E Ojerholm;A Smith;W-T Hwang;B Baumann;KN Tucker;SP Lerner;R Mamtani;B Boursi;JP Christodouleas
Journal / Conference
Cancer 2017 Mar 1;123(5):794-801; Oct 27. doi: 10.1002/cncr.30422. [Epub ahead of print]
Year
2016
Research Committee(s)
Genitourinary
PMID
PMID27787873
PMC
PMC5319875
Study Number(s)
SWOG-8710 (INT-0080) (EST-1887) (CALGB-8891)

HLA Haplotypes Are Associated with Multiple Myeloma Risk in the African American Multiple Myeloma Study (AAMMS)

Authors
L Gragert;A Hwang;L Bernal-Mizrachi;S Ailawadhi;S Singhal;D Vandenberg;X Sheng;A Stram;DV Conti;K Rand;C Song;JJ Graff;N Janakiraman;J Mehta;D Stram;C Bock;L Kolonel;G Colditz;A Mohrbacher;ES Peters;HR Terebelo;AK Nooka;R Vij;P Hari;M Beksac;BC-H Chiu;MH Tomasson;JA Zonder;CA Huff;RZ Orlowski;S Lonial;CA Haiman;W Cozen
Journal / Conference
Blood 128:3250; American Society of Hematology Annual Meeting (December 3-6, 2016, San Diego, CA), poster, abst. #3250
Year
2016
Research Committee(s)
Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
Study Number(s)
S0000

Discovery of molecular predictors of late breast cancer specific events (BCSE) in ER+, node+ breast cancer - new transcriptome expression whole gene analysis of the phase III adjuvant trial SWOG S8814

Authors
K Albain;M Crager;W Barlow;F Baehner;A Bergamaschi;JM Rae;P Ravdin;D Tripathy;J Gralow;RB Livingston;CK Osborne;JN Ingle;K Pritchard;NE Davidson;LA Carey;DB Cherbavaz;AP Sing;G Hortobagyi;DF Hayes
Journal / Conference
San Antonio Breast Cancer Symposium (Dec 6-10, 2016, San Antonio, TX), poster discussion, #PD7-07
Year
2016
Research Committee(s)
Breast
Study Number(s)
SWOG-8814

E1505: Adjuvant chemotherapy +/- bevacizumab for early stage NSCLC—Outcomes based on chemotherapy subsets

Authors
H Wakelee;S Dahlberg;S Keller;W Tester;D Gandara;S Graziano;A Adjei;N Leighl;C Butts;S Aisner;J Rothman;J Patel;M Sborov;R McDermott;R Perez-Soler;A Traynor;T Evans;L Horn;S Ramalingam;J Schiller
Journal / Conference
Journal of Clinical Oncology 34, 2016 (suppl; abstr 8507); American Society of Clinical Oncology Annual Meeting (June 3-7, 2016, Chicago, IL), oral session
Year
2016
Research Committee(s)
Lung
Study Number(s)
CTSU/E1505

Enrollment trends and disparity among patients with lung cancer in national clinical trials, 1990 to 2012

Authors
HH Pang;X Wang;T Stinchcombe;M Wong;P Cheng;AK Ganti;D Sargent;Y Zhang;C Hu;S Mandrekar;M Redman;J Manola;R Schilsky;H Cohen;J Bradley;A Adjei;D Gandara;S Ramalingam;E Vokes
Journal / Conference
Journal of Clinical Oncology Nov 20 34(33):3992-3999; 2016 Sep 19 [Epub ahead of print]
Year
2016
Research Committee(s)
Lung
PMID
PMID27646951
PMC
PMC5477832

MGUS to myeloma: a mysterious gammopathy of underexplored significance

Authors
M Dhodapkar
Journal / Conference
Blood 128:2599-2606 [Perspectives]
Year
2016
Research Committee(s)
Myeloma
PMID
PMID27737890
PMC
PMC5146746
Study Number(s)
S0120

Breast cancer outlook for 2017: keeping the accelerator to the floor

Authors
V Gadi;J Gralow
Journal / Conference
Oncology (Williston Park)
Year
2016
Research Committee(s)
Breast
PMID
PMID27933601
Study Number(s)
S1416

Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II–III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance)

Authors
M Golshan;C Cirrincione;W Sikov;LA Carey;DA Berry;BA Overmoyer;NL Henry;G Somlo;E Port;H Burstein;C Hudis;E Winer;D Ollila
Journal / Conference
Breast Cancer Research and Treatment
Year
2016
Research Committee(s)
Breast
PMID
PMID27704226
PMC
PMC5189982